Apyx Medical Corporation
General ticker "APYX" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $129.8M (TTM average)
Apyx Medical Corporation follows the US Stock Market performance with the rate: 47.3%.
Estimated limits based on current volatility of 2.5%: low 4.17$, high 4.38$
Factors to consider:
- Total employees count: 205 (-6.8%) as of 2025
- US accounted for 70.7% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Operating losses, Financing risks, Economic downturns and volatility, Product liability, Labor/talent shortage/retention
- Price in estimated range
- Earnings for 3 months up through Q1 are close to our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [2.53$, 5.86$]
- 2026-12-31 to 2027-12-31 estimated range: [2.13$, 5.02$]
Financial Metrics affecting the APYX estimates:
- Positive: with PPE of -13.2 at the end of fiscal year the price was neutral
- Negative: negative Operating cash flow
- Negative: negative Operating income
- Positive: Industry inventory ratio change (median), % of 0.25 <= 0.28
- Positive: -4.39 < Investing cash flow per share per price, % of -0.74
- Positive: 19.19 < Shareholder equity ratio, % of 21.75 <= 42.57
- Negative: negative Net income
Short-term APYX quotes
Long-term APYX plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $52.35MM | $47.94MM | $52.94MM |
| Operating Expenses | $69.61MM | $66.79MM | $59.38MM |
| Operating Income | $-17.26MM | $-18.84MM | $-6.45MM |
| Non-Operating Income | $-4.02MM | $-4.46MM | $-4.39MM |
| Interest Expense | $2.48MM | $5.91MM | $5.59MM |
| R&D Expense | $4.84MM | $5.08MM | $3.37MM |
| Income(Loss) | $-21.28MM | $-23.31MM | $-10.84MM |
| Taxes | $-2.43MM | $0.25MM | $0.27MM |
| Net Income(Loss)* | $-18.71MM | $-23.46MM | $-11.21MM |
| Stockholders Equity | $26.70MM | $14.21MM | $14.54MM |
| Inventory | $9.92MM | $7.56MM | $8.60MM |
| Assets | $79.24MM | $64.84MM | $66.84MM |
| Operating Cash Flow | $-5.25MM | $-18.05MM | $-8.00MM |
| Capital expenditure | $0.53MM | $0.72MM | $1.11MM |
| Investing Cash Flow | $6.73MM | $-0.72MM | $-1.11MM |
| Financing Cash Flow | $32.17MM | $6.75MM | $9.58MM |
| Earnings Per Share** | $-0.54 | $-0.66 | $-0.27 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.